TORSEMIDE Side Effects

7018603-7 | Anaemia, Benign Prostatic Hyperplasia, Cholelithiasis, Coma Hepatic, Hepatic Encephalopathy, Hyponatraemia
on Sep 13, 2010 Male patient from SPAIN , 88 years of age, was treated with Torsemide (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, benign prostatic hyperplasia, cholelithiasis, coma hepatic, hepatic encephalopathy, hyponatraemia. Torsemide dosage: 5 Mg (5 Mg, 1 In D), Oral. During the same period patient was treated with ALDACTONE (1.5 Dosage Forms (1.5 Dosage Forms, 1 In 1 D), Oral) (View Aldactone Review and Aldactone Label ), TARDYFERON (ASCORBIC ACID, FERROUS SULFATE, MUCOPROTEOSE) (View Tardyferon (ascorbic Acid, Ferrous Sulfate, Mucoproteose) Review and Tardyferon (ascorbic Acid, Ferrous Sulfate, Mucoproteose) Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), OMNIC (TAMSULOSIN HCL) (View Omnic (tamsulosin Hcl) Review and Omnic (tamsulosin Hcl) Label ), RABEPRAZOLE SODIUM (View Rabeprazole Sodium Review and Rabeprazole Sodium Label ), DUPHALAC (View Duphalac Review and Duphalac Label ). Patient was hospitalized.

7016376-5 | Condition Aggravated, Gastrointestinal Disorder, Renal Cyst, Renal Failure Chronic
Patient was taking Torsemide (View Usage). Patient had the following side effects: condition aggravated, gastrointestinal disorder, renal cyst, renal failure chronic on Sep 08, 2010 from SWITZERLAND Additional patient health information: Male patient , 88 years of age, . Torsemide dosage: . During the same period patient was treated with ATACAND (Oral) (View Atacand Review and Atacand Label ), LASIX (Oral) (View Lasix Review and Lasix Label ), AVODART (View Avodart Review and Avodart Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), METOPROLOL SUCCINATE (View Metoprolol Succinate Review and Metoprolol Succinate Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

6992951-9 | Erythema, Oedema Peripheral, Pruritus
Adverse event was reported on Sep 16, 2010 by a Female patient taking Torsemide (View Usage) (Dosage: 40mg Twice Daily Po, Two Doses) was diagnosed with cardiac failure congestive and. Location: UNITED STATES , 78 years of age, weighting 201.5 lb, After Torsemide was administered, patient had the following side effects: erythema, oedema peripheral, pruritus.

6980477-8 | Alopecia, Blood Creatinine Increased, Pruritus, Rash Maculo-papular, Skin Lesion
on Aug 25, 2010 Female patient from , 75 years of age, was diagnosed with hyperuricaemia and was treated with Torsemide (View Usage). Patient experienced the following unwanted or unexpected effects: alopecia, blood creatinine increased, pruritus, rash maculo-papular, skin lesion. Torsemide dosage: 5 Mg, (5 Mg, 1 In 1 D), Oral. During the same period patient was treated with CELLIDRIN (150 Mg (300 Mg, 1 In 2 D),oral) (View Cellidrin Review and Cellidrin Label ), LISINOPRIL (5 Mg (5 Mg, 1 In 1 D), Oral) (View Lisinopril Review and Lisinopril Label ). Patient was hospitalized.


6971727-2 | Coordination Abnormal, Hypertension, Hypotension, Sleep Disorder
on Aug 20, 2010 Female patient from GERMANY , 80 years of age, was diagnosed with back pain (What is back pain?), sleep disorder (What is sleep disorder?), hypertension and was treated with Torsemide (View Usage). Patient had the following side effects: coordination abnormal, hypertension, hypotension, sleep disorder (What is sleep disorder?). Torsemide dosage: 200 Mg (200 Mg, 1 In 1 D), Oral. During the same period patient was treated with GELONIDA (PARACETAMOL, CODEINE PHOSPHATE) (1 Tablet (1 Tablet, 1 In 1 D), Oral) (View Gelonida (paracetamol, Codeine Phosphate) Review and Gelonida (paracetamol, Codeine Phosphate) Label ), FLUNITRAZEPAM (FLUNITRAZEPAM) (2 Mg (1 Mg, Taken Irregularly), Oral) (View Flunitrazepam (flunitrazepam) Review and Flunitrazepam (flunitrazepam) Label ), METOPROLOL SUCCINATE (50 Mg (50 Mg, 1 In 1 D), Oral) (View Metoprolol Succinate Review and Metoprolol Succinate Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), MOLSIDOMINE (MOLSIDOMINE) (View Molsidomine (molsidomine) Review and Molsidomine (molsidomine) Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), BEZAFIBRATE (BEZAFIBRATE) (View Bezafibrate (bezafibrate) Review and Bezafibrate (bezafibrate) Label ). Patient was hospitalized.

6969386-8 | Blood Potassium Increased
Patient was taking Torsemide (View Usage). After Torsemide was administered, patient had the following side effects: blood potassium increased on Aug 19, 2010 from JAPAN Additional patient health information: Female patient , 67 years of age, . Torsemide dosage: 0.48 Mg/kg/day; 1.42 Mg/kg/day.

6945476-0 | Renal Failure Acute
Adverse event was reported on Aug 26, 2010 by a Female patient taking Torsemide (View Usage) (Dosage: 20 Mg, Bid) was diagnosed with hypertension, coronary artery disease (What is coronary artery disease?), osteoarthritis (What is osteoarthritis?), iron deficiency and. Location: GERMANY , 84 years of age, Patient experienced the following unwanted or unexpected effects: renal failure acute. During the same period patient was treated with ENALAPRIL MALEATE (20 Mg, Bid) (View Enalapril Maleate Review and Enalapril Maleate Label ), XIPAMID HEXAL (NGX) (20 Mg, Qd) (View Xipamid Hexal (ngx) Review and Xipamid Hexal (ngx) Label ), NORVASC (5 Mg, Bid) (View Norvasc Review and Norvasc Label ), METOPROLOL TARTRATE (100-0-50 Mg) (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), ASPIRIN (100 Mg, Qd) (View Aspirin Review and Aspirin Label ), FENTANYL CITRATE (12.5 Ug/hr, Unk) (View Fentanyl Citrate Review and Fentanyl Citrate Label ), PENTAERYTHRITOL TETRANITRATE (80 Mg, Tid) (View Pentaerythritol Tetranitrate Review and Pentaerythritol Tetranitrate Label ), HAEMOPROTECT (100 Mg, Bid) (View Haemoprotect Review and Haemoprotect Label ). Patient was hospitalized.

6894377-5 | Ascites, Communication Disorder, Hepatic Encephalopathy, Hepatic Function Abnormal, Nephrotic Syndrome
on Jul 08, 2010 Male patient from JAPAN , 65 years of age, was treated with Torsemide (View Usage). Patient had the following side effects: ascites, communication disorder, hepatic encephalopathy, hepatic function abnormal, nephrotic syndrome. Torsemide dosage: 4 Mg (4 Mg,1 In 1 D),oral. During the same period patient was treated with FLUITRAN (TRICHLORMETHIAZIDE) (View Fluitran (trichlormethiazide) Review and Fluitran (trichlormethiazide) Label ), MYCODYNE (CARBOCYSTEINE) (View Mycodyne (carbocysteine) Review and Mycodyne (carbocysteine) Label ), HOKUNALIN (TULOBUTEROL) (View Hokunalin (tulobuterol) Review and Hokunalin (tulobuterol) Label ).

6869784-7 | Hyponatraemia, Mental Disorder
on Jul 06, 2010 Female patient from , 72 years of age, was diagnosed with atrial fibrillation (What is atrial fibrillation?) and was treated with Torsemide (View Usage). After Torsemide was administered, patient had the following side effects: hyponatraemia, mental disorder. Torsemide dosage: 15 Mg (7.5 Mg, 2 In 1 D), Oral. During the same period patient was treated with SEROQUEL (75 Mg (25 Mg, 3 In 1 D), Oral) (View Seroquel Review and Seroquel Label ), LYRICA (View Lyrica Review and Lyrica Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), NACOM (CARBIDOPA, LEVODOPA) (View Nacom (carbidopa, Levodopa) Review and Nacom (carbidopa, Levodopa) Label ), LEFAX (SILICON DIOXIDE, COLLOIDAL, DIMETICONE) (View Lefax (silicon Dioxide, Colloidal, Dimeticone) Review and Lefax (silicon Dioxide, Colloidal, Dimeticone) Label ), INSULIN ACTRAPHANE (INSULIN HUMAN, ISOPHANE) (View Insulin Actraphane (insulin Human, Isophane) Review and Insulin Actraphane (insulin Human, Isophane) Label ), NEUPRO (View Neupro Review and Neupro Label ). Patient was hospitalized.

6860971-0 | Alopecia, Dehydration, Oedema Peripheral, Pulmonary Congestion, Renal Failure Acute, Septic Shock
Patient was taking Torsemide (View Usage). Patient experienced the following unwanted or unexpected effects: alopecia, dehydration, oedema peripheral, pulmonary congestion, renal failure acute, septic shock on Jul 01, 2010 from Additional patient health information: Female patient , 75 years of age, was diagnosed with hyperuricaemia, essential hypertension and. Torsemide dosage: 5 Mg (5 Mg, 1 In 1 D), Oral. During the same period patient was treated with CELLIDRIN (150 Mg (300 Mg, 1 In 2 D), Oral) (View Cellidrin Review and Cellidrin Label ), LISINOPRIL (5 Mg (5 Mg, 1 In 1 D), Oral) (View Lisinopril Review and Lisinopril Label ). Patient was hospitalized.

6860955-2 | Cardiac Failure, Congestive Cardiomyopathy, Diabetes Mellitus
Adverse event was reported on Jun 30, 2010 by a Female patient taking Torsemide (View Usage) (Dosage: 10 Mg (10 Mg, 1 In 1 D), Oral) was diagnosed with congestive cardiomyopathy, schizophrenia, cardiac failure and. Location: , 26 years of age, Patient had the following side effects: cardiac failure, congestive cardiomyopathy, diabetes mellitus. During the same period patient was treated with ABILIFY (10 Mg (10 Mg, 1 In 1 D), Oral; 15 Mg (15 Mg, 1 In 1 D), Oral) (View Abilify Review and Abilify Label ), XIPAMID (XIPAMIDE) (10 Mg (10 Mg, 1 In 1 D), Oral) (View Xipamid (xipamide) Review and Xipamid (xipamide) Label ), PANTOPRAZOL (PANTOPRAZOLE) (View Pantoprazol (pantoprazole) Review and Pantoprazol (pantoprazole) Label ), BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ), DIGITOXIN INJ (View Digitoxin Inj Review and Digitoxin Inj Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ). Patient was hospitalized.

6857902-6 | Deep Vein Thrombosis
on Jun 28, 2010 Female patient from GERMANY , 73 years of age, was diagnosed with oedema peripheral, rheumatoid arthritis (What is rheumatoid arthritis?), osteoporosis prophylaxis and was treated with Torsemide (View Usage). After Torsemide was administered, patient had the following side effects: deep vein thrombosis (What is deep vein thrombosis?). Torsemide dosage: 10 Mg (10 Mg, 1 In 1 D), Oral. During the same period patient was treated with TOCILIZUMAB (ROACTEMRA) (View Tocilizumab (roactemra) Review and Tocilizumab (roactemra) Label ), PREDNISOLONE (25 Mg (25 Mg, 1 In 1 D), Oral) (View Prednisolone Review and Prednisolone Label ), ARCOXIA (90 Mg (90 Mg, 1 In 1 D), Oral) (View Arcoxia Review and Arcoxia Label ), VITAMIN D (CALCIFEROL) (View Vitamin D (calciferol) Review and Vitamin D (calciferol) Label ), CALCIUM (CALCIUM) (View Calcium (calcium) Review and Calcium (calcium) Label ). Patient was hospitalized.

6787664-2 | Hyponatraemia
on Jun 04, 2010 Female patient from , 72 years of age, was diagnosed with atrial fibrillation (What is atrial fibrillation?) and was treated with Torsemide (View Usage). Patient experienced the following unwanted or unexpected effects: hyponatraemia. Torsemide dosage: 15 Mg (7.5 Mg, 2 In 1 D), Oral. During the same period patient was treated with SEROQUEL (75 Mg (25 Mg, 3 In 1 D), Oral) (View Seroquel Review and Seroquel Label ), LYRICA (View Lyrica Review and Lyrica Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), NACOM (CARBIDOPA, LEVODOPA) (View Nacom (carbidopa, Levodopa) Review and Nacom (carbidopa, Levodopa) Label ), LEFAX (SILICON DIOXIDE, COLLOIDAL, DIMETICONE) (View Lefax (silicon Dioxide, Colloidal, Dimeticone) Review and Lefax (silicon Dioxide, Colloidal, Dimeticone) Label ), INSULIN ACTRAPHANE (INSULIN HUMAN, ISOPHANE) (View Insulin Actraphane (insulin Human, Isophane) Review and Insulin Actraphane (insulin Human, Isophane) Label ), NEUPRO (View Neupro Review and Neupro Label ). Patient was hospitalized.

6787663-0 | Dialysis, Dyspnoea, Hypotension, Renal Failure Acute, Weight Increased
Patient was taking Torsemide (View Usage). Patient had the following side effects: dialysis (What is dialysis?), dyspnoea, hypotension, renal failure acute, weight increased on Jun 04, 2010 from Additional patient health information: Male patient , 69 years of age, was diagnosed with essential hypertension and. Torsemide dosage: 20 Mg (20 Mg, 1 In 1 D), Oral. During the same period patient was treated with MICARDIS (160 Mg (160 Mg, 1 In 1 D), Oral) (View Micardis Review and Micardis Label ), NEBILET (NEBIVOLOL HCL) (2.5 Mg (2.5 Mg, 1 In 1 D), Oral) (View Nebilet (nebivolol Hcl) Review and Nebilet (nebivolol Hcl) Label ), ZANIDIP (LERCANIDIPINE HCL) (10 Mg (10 Mg, 1 In 1 D), Oral) (View Zanidip (lercanidipine Hcl) Review and Zanidip (lercanidipine Hcl) Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), PRAVASTATIN (View Pravastatin Review and Pravastatin Label ), SINTROM (View Sintrom Review and Sintrom Label ). Patient was hospitalized.

6782127-2 | Dyspnoea, Hypercapnia, Hyponatraemia
Adverse event was reported on May 31, 2010 by a Female patient taking Torsemide (View Usage) (Dosage: 5 Mg (5 Mg, 1 In 1 D), Oral) . Location: , 79 years of age, After Torsemide was administered, patient had the following side effects: dyspnoea, hypercapnia, hyponatraemia. During the same period patient was treated with METOLAZON (METOLAZONE) (2.5 Mg (2.5 Mg 1 In 1 D), Oral) (View Metolazon (metolazone) Review and Metolazon (metolazone) Label ), SINTROM (View Sintrom Review and Sintrom Label ), CORDARONE (View Cordarone Review and Cordarone Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ), PANTOPRAZOLE SODIUM (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ). Patient was hospitalized.

6782101-6 | Antithrombin Iii Increased, Blood Homocysteine Increased, Colitis, Deep Vein Thrombosis, Dehydration, Diarrhoea, Fibrin D Dimer Increased, Prothrombin Time Prolonged
on Jun 02, 2010 Male patient from GERMANY , 84 years of age, weighting 180.8 lb, was diagnosed with oedema peripheral, chronic obstructive pulmonary disease and was treated with Torsemide (View Usage). Patient experienced the following unwanted or unexpected effects: antithrombin iii increased, blood homocysteine increased, colitis, deep vein thrombosis (What is deep vein thrombosis?), dehydration, diarrhoea, fibrin d dimer increased, prothrombin time prolonged. Torsemide dosage: 10 Mg (10 Mg, 1 In 1 D), Oral. During the same period patient was treated with THEOPHYLLINE (500 Mg (250 Mg, 2 In 1 D), Oral) (View Theophylline Review and Theophylline Label ), TAMSULOSIN HCL (View Tamsulosin Hcl Review and Tamsulosin Hcl Label ), ISOSORBIDE MONONITRATE (View Isosorbide Mononitrate Review and Isosorbide Mononitrate Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), PANTOPRAZOLE SODIUM (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ), MUCOFALK (PSYLLIUM HYDROPHILIC MUCILLOID) (View Mucofalk (psyllium Hydrophilic Mucilloid) Review and Mucofalk (psyllium Hydrophilic Mucilloid) Label ). Patient was hospitalized.

6763744-2 | Venous Thrombosis
on Jun 08, 2010 Male patient from GERMANY , 84 years of age, weighting 180.8 lb, was diagnosed with hyperuricaemia, reflux oesophagitis and was treated with Torsemide (View Usage). Patient had the following side effects: venous thrombosis. Torsemide dosage: . During the same period patient was treated with THEOPHYLLINE (View Theophylline Review and Theophylline Label ), TAMSULOSIN HCL (View Tamsulosin Hcl Review and Tamsulosin Hcl Label ), ISMN (View Ismn Review and Ismn Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), PANTOZOL (View Pantozol Review and Pantozol Label ), MUCOFALK (View Mucofalk Review and Mucofalk Label ). Patient was hospitalized.

6759522-0 | Hyperkalaemia, Renal Failure Acute
Patient was taking Torsemide (View Usage). After Torsemide was administered, patient had the following side effects: hyperkalaemia, renal failure acute on May 19, 2010 from Additional patient health information: Female patient , 82 years of age, weighting 218.3 lb, . Torsemide dosage: 20 Mg (20 Mg, 1 In 1 D), Oral. During the same period patient was treated with ALDACTONE (150 Mg (150 Mg, 1 In 1 D), Oral) (View Aldactone Review and Aldactone Label ), ACCURETIC (HYDROCHLOROTHIAZIDE, QUINAPRIL HC1) (25 Mg (25 Mg, 1 In 1 D), Oral) (View Accuretic (hydrochlorothiazide, Quinapril Hc1) Review and Accuretic (hydrochlorothiazide, Quinapril Hc1) Label ), METFIN (View Metfin Review and Metfin Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), MARCUMAR (View Marcumar Review and Marcumar Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ). Patient was hospitalized.

6756917-6 | Dizziness, Fall, Sedation, Weight Decreased
Adverse event was reported on Jun 03, 2010 by a Male patient taking Torsemide (View Usage) (Dosage: 200 Mg Tid Po) was diagnosed with cardiac failure congestive and. Location: UNITED STATES , 60 years of age, weighting 211.6 lb, Patient experienced the following unwanted or unexpected effects: dizziness (What is dizziness?), fall (What is fall?), sedation, weight decreased. During the same period patient was treated with LORAZEPAM (View Lorazepam Review and Lorazepam Label ).

6742451-6 | Cardiac Failure High Output, No Therapeutic Response, Nystagmus, Pulmonary Congestion, Pulmonary Hypertension, Tricuspid Valve Incompetence, Vitamin B1 Deficiency, Wernicke's Encephalopathy
on May 12, 2010 Male patient from JAPAN , 61 years of age, weighting 130.1 lb, was diagnosed with electrocardiogram st segment elevation and was treated with Torsemide (View Usage). Patient had the following side effects: cardiac failure high output, no therapeutic response, nystagmus, pulmonary congestion, pulmonary hypertension (What is pulmonary hypertension?), tricuspid valve incompetence, vitamin b1 deficiency, wernicke's encephalopathy. Torsemide dosage: 8 Mg (8 Mg, 1 In 1 D). During the same period patient was treated with LOSARTAN POTASSIUM (View Losartan Potassium Review and Losartan Potassium Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), MECOBALAMINE (MECOBALAMINE) (View Mecobalamine (mecobalamine) Review and Mecobalamine (mecobalamine) Label ). Patient was hospitalized.

6736546-0 | Renal Failure Acute
on May 01, 2010 Female patient from SWITZERLAND , 51 years of age, was treated with Torsemide (View Usage). After Torsemide was administered, patient had the following side effects: renal failure acute. Torsemide dosage: 20 Mg (20 Mg, 1 In 1 D), Oral. During the same period patient was treated with COZAAR (100 Mg, (100 Mg, 1 In 1 D), Oral) (View Cozaar Review and Cozaar Label ), ALDACTONE (50 Mg (50 Mg, 1 In 1 D), Oral) (View Aldactone Review and Aldactone Label ), BACTRIM (View Bactrim Review and Bactrim Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), CARVEDILOL (View Carvedilol Review and Carvedilol Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), SINTROM (View Sintrom Review and Sintrom Label ), DALACIN (CLINDAMYCIN) (View Dalacin (clindamycin) Review and Dalacin (clindamycin) Label ). Patient was hospitalized.

6719784-2 | Acute Prerenal Failure, Blood Pressure Diastolic Decreased, Blood Sodium Decreased, Dehydration, Depressed Level Of Consciousness, Dry Skin, Erythema, Fall
Patient was taking Torsemide (View Usage). Patient experienced the following unwanted or unexpected effects: acute prerenal failure, blood pressure diastolic decreased, blood sodium decreased, dehydration, depressed level of consciousness, dry skin, erythema, fall (What is fall?) on Apr 19, 2010 from GERMANY Additional patient health information: Female patient , 84 years of age, weighting 158.7 lb, was diagnosed with hypertension, stress urinary incontinence, vascular dementia and. Torsemide dosage: (5 Mg), Oral. During the same period patient was treated with XIPAMID (XIPAMIDE) ((10 Mg), Oral) (View Xipamid (xipamide) Review and Xipamid (xipamide) Label ), SPIRONOLACTONE ((25 Mg), Oral) (View Spironolactone Review and Spironolactone Label ), RAMIPRIL ((2.5 Mg), Oral) (View Ramipril Review and Ramipril Label ), MICTONORM (PROPIVERINE HCL) ((15 Mg), Oral) (View Mictonorm (propiverine Hcl) Review and Mictonorm (propiverine Hcl) Label ), MELPERON (MELPERONE HCL) ((25 Mg), Oral) (View Melperon (melperone Hcl) Review and Melperon (melperone Hcl) Label ), AKINETON (View Akineton Review and Akineton Label ), ZOLPIDEM AL (ZOLPIDEM) (View Zolpidem Al (zolpidem) Review and Zolpidem Al (zolpidem) Label ), PANTOPRAZOL (PANTOPRAZOLE) (View Pantoprazol (pantoprazole) Review and Pantoprazol (pantoprazole) Label ). Patient was hospitalized.

6718667-1 | Adrenal Disorder, Arthralgia, Blood Pressure Decreased, Bradycardia, Breast Cancer, Cardiac Failure, Chest Pain, Deep Vein Thrombosis, Face Oedema
Adverse event was reported on Apr 08, 2010 by a Female patient taking Torsemide (View Usage) (Dosage: Oral) was diagnosed with oedema due to cardiac disease, breast cancer (What is breast cancer?) and. Location: , 65 years of age, Patient had the following side effects: adrenal disorder, arthralgia, blood pressure decreased, bradycardia, breast cancer (What is breast cancer?), cardiac failure, chest pain (What is chest pain?), deep vein thrombosis (What is deep vein thrombosis?), face oedema. During the same period patient was treated with SUNITINIB MALATE (37.5 Mg (37.5 Mg, 1 In 1 D), Oral) (View Sunitinib Malate Review and Sunitinib Malate Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), CANDESARTAN (CANDESARTAN CILEXETIL) (View Candesartan (candesartan Cilexetil) Review and Candesartan (candesartan Cilexetil) Label ), CARVEDILOL (View Carvedilol Review and Carvedilol Label ), REBAMIPIDE (REBAMIPIDE) (View Rebamipide (rebamipide) Review and Rebamipide (rebamipide) Label ), LOXOPROFEN (LOXOPROFEN) (View Loxoprofen (loxoprofen) Review and Loxoprofen (loxoprofen) Label ), DICLOFENAC SODIUM (View Diclofenac Sodium Review and Diclofenac Sodium Label ). Patient was hospitalized.

6709060-6 | Blood Pressure Decreased, Cardiac Failure High Output, Dyspnoea, Electrocardiogram St Segment Elevation, Eyelid Ptosis, Gait Disturbance, Hypoaesthesia, Malaise, Muscle Disorder
on Apr 14, 2010 Male patient from JAPAN , 61 years of age, was diagnosed with electrocardiogram st segment elevation and was treated with Torsemide (View Usage). After Torsemide was administered, patient had the following side effects: blood pressure decreased, cardiac failure high output, dyspnoea, electrocardiogram st segment elevation, eyelid ptosis, gait disturbance, hypoaesthesia, malaise, muscle disorder (What is muscle disorder?). Torsemide dosage: 8 Mg (8 Mg, 1 In 1 D). During the same period patient was treated with LOSARTAN POTASSIUM (View Losartan Potassium Review and Losartan Potassium Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), MECOBALAMINE (MECOBALAMINE) (View Mecobalamine (mecobalamine) Review and Mecobalamine (mecobalamine) Label ). Patient was hospitalized.

6700795-8 | Bicytopenia, Blood Pressure Diastolic Decreased, Dehydration, Erythropoiesis Abnormal, Hyperkalaemia, Megakaryocytes Decreased, Renal Failure Acute
on Apr 09, 2010 Female patient from GERMANY , 70 years of age, weighting 154.3 lb, was diagnosed with hypertension, pain (What is pain?) and was treated with Torsemide (View Usage). Patient experienced the following unwanted or unexpected effects: bicytopenia, blood pressure diastolic decreased, dehydration, erythropoiesis abnormal, hyperkalaemia, megakaryocytes decreased, renal failure acute. Torsemide dosage: 10 Mg (10 Mg, 1 In 1 D), Oral. During the same period patient was treated with ENEAS (NITRENDIPINE, ENALAPRIL MALEATE) (10mg Enalapril + 20mg Nitrendipin (1 Dosage Forms, 1 In 1 D), Oral) (View Eneas (nitrendipine, Enalapril Maleate) Review and Eneas (nitrendipine, Enalapril Maleate) Label ), BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE (5mg Bisoprolol + 12.5 Hct (1 Dose Forms, 1 In 1 D), Oral) (View Bisoprolol Fumarate And Hydrochlorothiazide Review and Bisoprolol Fumarate And Hydrochlorothiazide Label ), SPIRONOLACTONE (25 Mg (25 Mg, 1 In 1 D), Oral) (View Spironolactone Review and Spironolactone Label ), DOXAZOSIN MESYLATE (4 Mg (4 Mg, 1 In 1 D), Oral) (View Doxazosin Mesylate Review and Doxazosin Mesylate Label ), VENLAFAXINE HCL (75 Mg (37.5 Mg, 2 In 1 D), Oral) (View Venlafaxine Hcl Review and Venlafaxine Hcl Label ), DICLOFENAC SODIUM (50 Mg (50 Mg, 1 In 1 D), Oral) (View Diclofenac Sodium Review and Diclofenac Sodium Label ), DIGITOXIN (0.07 Mg (0.07 Mg, 1 In 1 D), Oral) (View Digitoxin Review and Digitoxin Label ). Patient was hospitalized.

6700482-6 | Abdominal Discomfort, Activated Partial Thromboplastin Time Prolonged, Alveolitis, Blood Potassium Decreased, Dyspnoea, Hepatitis, Nausea, Pleurisy
Patient was taking Torsemide (View Usage). Patient had the following side effects: abdominal discomfort, activated partial thromboplastin time prolonged, alveolitis, blood potassium decreased, dyspnoea, hepatitis (What is hepatitis?), nausea (What is nausea?), pleurisy on Apr 12, 2010 from GERMANY Additional patient health information: Female patient , 80 years of age, was diagnosed with hypertension, rheumatoid arthritis (What is rheumatoid arthritis?), tachyarrhythmia, hyperlipidaemia, restlessness, prophylaxis against gastrointestinal ulcer and. Torsemide dosage: 200 Mg (200 Mg, 1 In 1 D), Oral. During the same period patient was treated with METHOTREXATE (1.4286 Mg (10 Mg, 1 In 1 Wk), Subcutaneous) (View Methotrexate Review and Methotrexate Label ), RAMIPRIL (2.5 Mg (2.5 Mg, 1 In 1 D), Oral, 1.25 Mg (1.25 Mg, 1 In 1 D), Oral) (View Ramipril Review and Ramipril Label ), FALITHROM (PHENPROCOUMON) (3 Mg (3 Mg, 1 In 1 D, Oral) (View Falithrom (phenprocoumon) Review and Falithrom (phenprocoumon) Label ), SIMVASTATIN (40 Mg (40 Mg, 1 In 1 D), Oral) (View Simvastatin Review and Simvastatin Label ), SEROQUEL (25 Mg (25 Mg, 1 In 1 D), Oral) (View Seroquel Review and Seroquel Label ), CORDANUM (TALINOLOL) (50 Mg (50 Mg, 1n 1 D), Oral) (View Cordanum (talinolol) Review and Cordanum (talinolol) Label ), OMEPRAZOLE (20 Mg (20 Mg, 1 In 1 D), Oral) (View Omeprazole Review and Omeprazole Label ). Patient was hospitalized.

6697766-7 | Atrial Fibrillation, Diarrhoea, Dizziness, Fall, Nausea, Renal Failure, Therapeutic Agent Toxicity, Urinary Tract Infection
Adverse event was reported on Apr 09, 2010 by a Female patient taking Torsemide (View Usage) (Dosage: 5 Mg (5 M, 1 In 1d), Oral; 2.5 Mg/day) was diagnosed with cardiac failure chronic, hypertension and. Location: , 87 years of age, After Torsemide was administered, patient had the following side effects: atrial fibrillation (What is atrial fibrillation?), diarrhoea, dizziness (What is dizziness?), fall (What is fall?), nausea (What is nausea?), renal failure, therapeutic agent toxicity, urinary tract infection (What is urinary tract infection?). During the same period patient was treated with DIGITOXIN TAB (0.07 Mg (0.07 Mg, 1 In 1d),oral) (View Digitoxin Tab Review and Digitoxin Tab Label ), VOTUM (OLMESARTAN, HYDROCHLOROTHIAZIDE) (20 Mg Olmesartan + 12.5 Mg Hydrochlorothiazide (1 Dosage Forms , 2 In 1 D), Oral) (View Votum (olmesartan, Hydrochlorothiazide) Review and Votum (olmesartan, Hydrochlorothiazide) Label ), L THYROXINE LEVOTHYROXINE) (View L-thyroxine Levothyroxine) Review and L-thyroxine Levothyroxine) Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), BROMHEXINE (BROMHEXINE) (View Bromhexine (bromhexine) Review and Bromhexine (bromhexine) Label ), PERENTEROL (YEAST DRIED) (View Perenterol (yeast Dried) Review and Perenterol (yeast Dried) Label ), ROMYK (ROXITHROMYCIN) (View Romyk (roxithromycin) Review and Romyk (roxithromycin) Label ). Patient was hospitalized.

6658770-8 | Acute Prerenal Failure, Atrioventricular Block Complete, Bradycardia, Bundle Branch Block Right, Cardiac Arrest, Electrocardiogram Poor R-wave Progression, Hyperkalaemia, Nocturnal Dyspnoea, Oedema Peripheral
on Mar 10, 2010 Male patient from INDIA , 78 years of age, was treated with Torsemide (View Usage). Patient experienced the following unwanted or unexpected effects: acute prerenal failure, atrioventricular block complete, bradycardia, bundle branch block right, cardiac arrest (What is cardiac arrest?), electrocardiogram poor r-wave progression, hyperkalaemia, nocturnal dyspnoea, oedema peripheral. Torsemide dosage: 20 Mg, Per Day. During the same period patient was treated with RAMIPRIL (10 Mg (5mg, 2 In 1 D)) (View Ramipril Review and Ramipril Label ), DIGOXIN ((0.125 Mg, Per Day)) (View Digoxin Review and Digoxin Label ), STATINS (View Statins Review and Statins Label ), PLATELET INHIBITORS (View Platelet Inhibitors Review and Platelet Inhibitors Label ). Patient was hospitalized.

6658770-8 | Acute Prerenal Failure, Atrioventricular Block Complete, Bradycardia, Bundle Branch Block Right, Cardiac Arrest, Electrocardiogram Poor R-wave Progression, Hyperkalaemia, Nocturnal Dyspnoea, Oedema Peripheral
on Mar 10, 2010 Male patient from INDIA , 78 years of age, was treated with Torsemide (View Usage). Patient had the following side effects: acute prerenal failure, atrioventricular block complete, bradycardia, bundle branch block right, cardiac arrest (What is cardiac arrest?), electrocardiogram poor r-wave progression, hyperkalaemia, nocturnal dyspnoea, oedema peripheral. Torsemide dosage: 20 Mg, Per Day. During the same period patient was treated with RAMIPRIL (10 Mg (5mg, 2 In 1 D)) (View Ramipril Review and Ramipril Label ), DIGOXIN ((0.125 Mg, Per Day)) (View Digoxin Review and Digoxin Label ), STATINS (View Statins Review and Statins Label ), PLATELET INHIBITORS (View Platelet Inhibitors Review and Platelet Inhibitors Label ). Patient was hospitalized.

6643979-X |
Patient was taking Torsemide (View Usage). on Mar 18, 2010 from UNITED STATES Additional patient health information: Male patient , 67 years of age, weighting 280.0 lb, was diagnosed with fluid retention and. Torsemide dosage: 1 Tablet Every Day Mouth.

6612613-7 | Gallbladder Non-functioning, Hyperhidrosis, Liver Disorder, Oedematous Pancreatitis
Adverse event was reported on Feb 03, 2010 by a Male patient taking Torsemide (View Usage) (Dosage: Oral) was diagnosed with hypertension, benign prostatic hyperplasia, cardiac fibrillation and. Location: , 78 years of age, weighting 198.4 lb, Patient experienced the following unwanted or unexpected effects: gallbladder non-functioning, hyperhidrosis, liver disorder, oedematous pancreatitis. During the same period patient was treated with TAMSULOSIN 0.4MG RETARD CAPSULE (0.4mg, Oral) (View Tamsulosin 0.4mg Retard Capsule Review and Tamsulosin 0.4mg Retard Capsule Label ), PHENPROCOUMON (FALITHROM) (3-9mg-daily-oral) (View Phenprocoumon (falithrom) Review and Phenprocoumon (falithrom) Label ), VALSARTAN AND HYDROCHLOROTHIAZIDE (1df-daily-oral) (View Valsartan And Hydrochlorothiazide Review and Valsartan And Hydrochlorothiazide Label ). Patient was hospitalized.

6600327-9 | Activated Partial Thromboplastin Time Prolonged, Blood Glucose Increased, Gallbladder Non-functioning, Haemoglobin Decreased, International Normalised Ratio Increased, Oedematous Pancreatitis, Pancreatitis Acute
on Jan 25, 2010 Male patient from GERMANY , 78 years of age, was diagnosed with hypertension, atrial fibrillation (What is atrial fibrillation?) and was treated with Torsemide (View Usage). Patient had the following side effects: activated partial thromboplastin time prolonged, blood glucose increased, gallbladder non-functioning, haemoglobin decreased, international normalised ratio increased, oedematous pancreatitis, pancreatitis acute. Torsemide dosage: Oral. During the same period patient was treated with FALITHIROM (PHENPROCOUMON) (3 Mg (3 Mg, 1 In 1 D), Oral) (View Falithirom (phenprocoumon) Review and Falithirom (phenprocoumon) Label ), DIOVAN HCT (40 Mg Valsartan/6.25 Mg Hctz (1 Dosage Forms, 1 In 1 D), Oral) (View Diovan Hct Review and Diovan Hct Label ), TAMSULOSIN HCL (View Tamsulosin Hcl Review and Tamsulosin Hcl Label ). Patient was hospitalized.

6598074-5 | Pneumonia, Pulmonary Embolism
on Jan 29, 2010 Male patient from GERMANY , 75 years of age, was diagnosed with nephrogenic anaemia and was treated with Torsemide (View Usage). After Torsemide was administered, patient had the following side effects: pneumonia (What is pneumonia?), pulmonary embolism (What is pulmonary embolism?). Torsemide dosage: 10 Mg (10 Mg, 1 In 1 D), Oral. During the same period patient was treated with METHOXY POLYETHYLENE GLYCOL EPOETIN BETA (METHOXY POLYETHYLENE GLYCOL ((50 Mcg, 1 In 1 M), Subcutanoeus) (View Methoxy Polyethylene Glycol-epoetin Beta (methoxy Polyethylene Glycol Review and Methoxy Polyethylene Glycol-epoetin Beta (methoxy Polyethylene Glycol Label ), SULFAMETHOXAZOLE AND TRIMETHOPRIM ((1 Dosage Forms, 3 In 1 Wk), Oral) (View Sulfamethoxazole And Trimethoprim Review and Sulfamethoxazole And Trimethoprim Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), AVELOX (View Avelox Review and Avelox Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ), NOVOMIX (INSULIN ASPART, PROTAMINE INSULIN ASPART) (View Novomix (insulin Aspart, Protamine Insulin Aspart) Review and Novomix (insulin Aspart, Protamine Insulin Aspart) Label ), IMUREK (AZATHIOPRINE) (View Imurek (azathioprine) Review and Imurek (azathioprine) Label ). Patient was hospitalized.

6598063-0 | Hypotension, Overdose, Syncope
Patient was taking Torsemide (View Usage). Patient experienced the following unwanted or unexpected effects: hypotension, overdose, syncope on Feb 01, 2010 from Additional patient health information: Female patient , 95 years of age, weighting 138.9 lb, was diagnosed with hypertension, coronary artery disease (What is coronary artery disease?), sleep disorder (What is sleep disorder?) and. Torsemide dosage: 5 Mg (5 Mg, 1 In 1 D), Oral. During the same period patient was treated with AMLODIPINE (5 Mg, (5 Mg, 1 In 1 D), Oral) (View Amlodipine Review and Amlodipine Label ), MOLSICOR (MOLSIDOMINE) (8 Mg (8 Mg, 1 In 1 D), Oral) (View Molsicor (molsidomine) Review and Molsicor (molsidomine) Label ), PENTAERYTHIRITOL TETRANITRATE TAB (160 Mg (80 Mg, 1 In 1 D), Oral) (View Pentaerythiritol Tetranitrate Tab Review and Pentaerythiritol Tetranitrate Tab Label ), MELPERONE (MELPERONE) (12.5 Mg (12.5 Mg, 12.5 Mg, At Night), Oral) (View Melperone (melperone) Review and Melperone (melperone) Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), METHIZOL (THIAMAZOLE) (View Methizol (thiamazole) Review and Methizol (thiamazole) Label ), PANTOPRAZOLE SODIUM (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ), TEBONIN (GINKO TREE LEAVES EXTRACT) (View Tebonin (ginko Tree Leaves Extract) Review and Tebonin (ginko Tree Leaves Extract) Label ). Patient was hospitalized.

6597832-0 | Acute Prerenal Failure, Atrial Fibrillation, Bronchitis, Dehydration, Diarrhoea, Hypophagia, Therapeutic Agent Toxicity, Urinary Tract Infection
Adverse event was reported on Jan 29, 2010 by a Female patient taking Torsemide (View Usage) (Dosage: 5 Mg (5 Mg, 1 In 1 D), Oral; After A Pause Administraton Continued At 1 X 2.5 Mg/day) was diagnosed with cardiac failure chronic, hypertension and. Location: GERMANY , 87 years of age, Patient had the following side effects: acute prerenal failure, atrial fibrillation (What is atrial fibrillation?), bronchitis (What is bronchitis?), dehydration, diarrhoea, hypophagia, therapeutic agent toxicity, urinary tract infection (What is urinary tract infection?). During the same period patient was treated with DIGITOXIN TAB (0.07 Mg (0.07 Mg, 1 In 1 Day), Oral) (View Digitoxin Tab Review and Digitoxin Tab Label ), VOTUM (OLMESARTAN, HYDROCHLOROTHIAZIDE) (20 Mg, Olmesartan + 12.5 Mg Hydrochlorothiazide (1 Dosage Forms, 2 In 1 D),oral) (View Votum (olmesartan, Hydrochlorothiazide) Review and Votum (olmesartan, Hydrochlorothiazide) Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), BROMHEXINE (BROMHEXINE) (View Bromhexine (bromhexine) Review and Bromhexine (bromhexine) Label ), PERENTEROL (YEAST DRIED) (View Perenterol (yeast Dried) Review and Perenterol (yeast Dried) Label ), ROMYK (ROXITHROMYCIN) (View Romyk (roxithromycin) Review and Romyk (roxithromycin) Label ), BISOHEXAL (BISOPROLOL HEMIFUMARATE) (View Bisohexal (bisoprolol Hemifumarate) Review and Bisohexal (bisoprolol Hemifumarate) Label ). Patient was hospitalized.

6597687-4 | Bicytopenia, Dehydration, Dry Skin, Erythropenia, Mucosal Dryness, Pallor, Renal Failure Acute, Thrombocytopenia
on Jan 29, 2010 Female patient from GERMANY , 70 years of age, weighting 154.3 lb, was diagnosed with hypertension, pain (What is pain?) and was treated with Torsemide (View Usage). After Torsemide was administered, patient had the following side effects: bicytopenia, dehydration, dry skin, erythropenia, mucosal dryness, pallor, renal failure acute, thrombocytopenia. Torsemide dosage: 10 Mg (10 Mg, 1 In 1 D), Oral. During the same period patient was treated with ENEAS (NITRENDIPINE, ENALAPRIL MALEATE) (10mg Enalapril + 20mg Nitrendipin (1 Dosage Forms, 1 In 1 D), Oral) (View Eneas (nitrendipine, Enalapril Maleate) Review and Eneas (nitrendipine, Enalapril Maleate) Label ), BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE (5mg Bisoprolol + 12.5 Hct (1 Dosage Forms, 1 In 1 D), Oral) (View Bisoprolol Fumarate And Hydrochlorothiazide Review and Bisoprolol Fumarate And Hydrochlorothiazide Label ), SPIRONOLACTONE (25 Mg (25 Mg, 1 In 1 D), Oral) (View Spironolactone Review and Spironolactone Label ), DOXAZOSIN MESYLATE (4 Mg (4 Mg, 1 In 1 D), Oral) (View Doxazosin Mesylate Review and Doxazosin Mesylate Label ), VENLAFAXINE HCL (75 Mg (37.5 Mg, 2 In 1 D), Oral) (View Venlafaxine Hcl Review and Venlafaxine Hcl Label ), DICLOFENAC SODIUM (50 Mg (50 Mg, 1 In 1 D), Oral) (View Diclofenac Sodium Review and Diclofenac Sodium Label ), DIGITOXIN (DIGTOXIN) (View Digitoxin (digtoxin) Review and Digitoxin (digtoxin) Label ). Patient was hospitalized.

6595124-7 | Condition Aggravated, Thrombocytopenia
on Jan 26, 2010 Female patient from , 60 years of age, was diagnosed with hypertension and was treated with Torsemide (View Usage). Patient experienced the following unwanted or unexpected effects: condition aggravated, thrombocytopenia. Torsemide dosage: (4 Mg), Oral. During the same period patient was treated with L ASPARTIC ACID (ASPARTIC ACID) (View L-aspartic Acid (aspartic Acid) Review and L-aspartic Acid (aspartic Acid) Label ), OLMETEC (OLMESARTAN MEDOXOMIL) (View Olmetec (olmesartan Medoxomil) Review and Olmetec (olmesartan Medoxomil) Label ), ACTONEL (View Actonel Review and Actonel Label ).

6593782-4 | Activated Partial Thromboplastin Time Prolonged, Amnesia, Atrial Fibrillation, Benign Prostatic Hyperplasia, Blood Calcium Increased, Blood Sodium Decreased, Bradycardia, Bundle Branch Block, Cardiovascular Disorder
Patient was taking Torsemide (View Usage). Patient had the following side effects: activated partial thromboplastin time prolonged, amnesia, atrial fibrillation (What is atrial fibrillation?), benign prostatic hyperplasia, blood calcium increased, blood sodium decreased, bradycardia, bundle branch block, cardiovascular disorder on Jan 27, 2010 from Additional patient health information: Male patient , 77 years of age, weighting 183.0 lb, was diagnosed with renal impairment, pain in extremity, arterial occlusive disease, gout (What is gout?), hypertension, atrial fibrillation (What is atrial fibrillation?), oedema peripheral and. Torsemide dosage: 20 Mg (20 Mg, 1 In 1 D), Oral. During the same period patient was treated with ARCOXIA (90 Mg (90 Mg, 1 In 1 D), Oral) (View Arcoxia Review and Arcoxia Label ), GABAPENTIN (600 Mg (300 Mg, 2 In 1 D), Oral) (View Gabapentin Review and Gabapentin Label ), BENZBROMARONE AL (BENZBROMARONE) (100 Mg (100 Mg, 1 In 1 D), Oral) (View Benzbromarone Al (benzbromarone) Review and Benzbromarone Al (benzbromarone) Label ), METOPROLOL TARTRATE (47.5 Mg (47.5mg, 1 In 1 D), Oral) (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), BENAZEPRIL HYDROCHLORIDE (BENAZEPRIL HCL) (1 Dosage Forms (1 Dosage Forms, 1 In 1 D), Oral) (View Benazepril Hydrochloride (benazepril Hcl) Review and Benazepril Hydrochloride (benazepril Hcl) Label ), DIGITOXIN INJ (0.07 Mg (0.7 Mg, 1 In 1 D), Oral) (View Digitoxin Inj Review and Digitoxin Inj Label ), SPIRONOLACTONE (25 Mg (25 Mg, 1 In 1 D), Oral) (View Spironolactone Review and Spironolactone Label ), XIPAMIDE (XIPAMIDE) (40 Mg (40 Mg, 1 In 1 D), Oral) (View Xipamide (xipamide) Review and Xipamide (xipamide) Label ). Patient was hospitalized.

6588763-0 | Atrial Fibrillation, Blood Sodium Decreased, Dyslipidaemia, Enteritis, Gastroenteritis Viral, Haematocrit Decreased, Haemoglobin Decreased, Hypertension
Adverse event was reported on Jan 26, 2010 by a Male patient taking Torsemide (View Usage) (Dosage: 10 Mg (10 Mg, 1 In 1 D), Oral) was diagnosed with hypertension, pyelonephritis, atrial fibrillation (What is atrial fibrillation?) and. Location: , 69 years of age, weighting 244.7 lb, After Torsemide was administered, patient had the following side effects: atrial fibrillation (What is atrial fibrillation?), blood sodium decreased, dyslipidaemia, enteritis, gastroenteritis viral, haematocrit decreased, haemoglobin decreased, hypertension. During the same period patient was treated with CIPROFLOXACIN HCL (500 Mg (250 Mg, 1 In 1 D), Oral) (View Ciprofloxacin Hcl Review and Ciprofloxacin Hcl Label ), LISIHEXAL COMP (LISINOPRIL, HYDROCHLOROTHIAZIDE) (20/12.5 Mg (1 Tablet, 2 In 1 D), Oral) (View Lisihexal Comp (lisinopril, Hydrochlorothiazide) Review and Lisihexal Comp (lisinopril, Hydrochlorothiazide) Label ), DIGITOXIN TAB (0.07 Mg (0.7 Mg, 1 In 1 D), Oral) (View Digitoxin Tab Review and Digitoxin Tab Label ), AGGRENOX (ACETYLLSALICIC ACID, DIPYRIDAMOLE) (View Aggrenox (acetyllsalicic Acid, Dipyridamole) Review and Aggrenox (acetyllsalicic Acid, Dipyridamole) Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), VERA 80 HEUMANN (VERAPAMIL) (View Vera 80 Heumann (verapamil) Review and Vera 80 Heumann (verapamil) Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ). Patient was hospitalized.

6579102-X | Blood Pressure Increased, Cerebral Arteriosclerosis, Cerebral Haemorrhage, Chest Pain, Encephalopathy, Inappropriate Antidiuretic Hormone Secretion, Osteochondrosis, Spinal Osteoarthritis
on Jan 21, 2010 Female patient from , 80 years of age, weighting 220.5 lb, was diagnosed with hypertension and was treated with Torsemide (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure increased, cerebral arteriosclerosis, cerebral haemorrhage, chest pain (What is chest pain?), encephalopathy, inappropriate antidiuretic hormone secretion, osteochondrosis, spinal osteoarthritis. Torsemide dosage: 2.5 Mg (2.5 Mg, 1 In 1 D), Oral. During the same period patient was treated with CARBAMAZEPINE (200 Mg (200 Mg, 1 In 1 D), Oral) (View Carbamazepine Review and Carbamazepine Label ), ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE (10 Mg/25 Mg (1 Dosage Forms, 1 In 1 D), Oral) (View Enalapril Maleate And Hydrochlorothiazide Review and Enalapril Maleate And Hydrochlorothiazide Label ), METOPROLOL (METOPROLOL) (View Metoprolol (metoprolol) Review and Metoprolol (metoprolol) Label ), NIFEDIPINE (View Nifedipine Review and Nifedipine Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ). Patient was hospitalized.

6578826-8 | Clostridium Difficile Colitis
on Jan 20, 2010 Male patient from , 81 years of age, was treated with Torsemide (View Usage). Patient had the following side effects: clostridium difficile colitis. Torsemide dosage: 10-5-0 Mg (2 In 1 D), Oral. During the same period patient was treated with CIPROFLOXACIN HCL (Oral) (View Ciprofloxacin Hcl Review and Ciprofloxacin Hcl Label ), PRAMIPEXOLE DIHYDROCHLORIDE (View Pramipexole Dihydrochloride Review and Pramipexole Dihydrochloride Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), MIRTAZAPINE (View Mirtazapine Review and Mirtazapine Label ), EXELON (View Exelon Review and Exelon Label ), LEVODOPA 100/25 (LEVODOPA, CARBIDOPA) (View Levodopa 100/25 (levodopa, Carbidopa) Review and Levodopa 100/25 (levodopa, Carbidopa) Label ). Patient was hospitalized.

6577138-6 | Syncope
Patient was taking Torsemide (View Usage). After Torsemide was administered, patient had the following side effects: syncope on Feb 01, 2010 from GERMANY Additional patient health information: Female patient , 95 years of age, weighting 138.9 lb, was diagnosed with hyperthyroidism and. Torsemide dosage: . During the same period patient was treated with AMLOBETA (View Amlobeta Review and Amlobeta Label ), MOLSICOR (View Molsicor Review and Molsicor Label ), PENTAERYTHRITOL TETRANITRATE (View Pentaerythritol Tetranitrate Review and Pentaerythritol Tetranitrate Label ), MELPERONE (Taken At Night.) (View Melperone Review and Melperone Label ), ACETYLSALICYLIC ACID (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), METHIZOL (View Methizol Review and Methizol Label ), PANTOZOL (View Pantozol Review and Pantozol Label ), TEBONIN (View Tebonin Review and Tebonin Label ). Patient was hospitalized.

6552861-8 | Platelet Count Decreased
Adverse event was reported on Jan 07, 2010 by a Female patient taking Torsemide (View Usage) (Dosage: (4 Mg), Oral) was diagnosed with hypertension and. Location: JAPAN , 60 years of age, Patient experienced the following unwanted or unexpected effects: platelet count decreased. During the same period patient was treated with L ASPARTIC ACID (ASPARTIC ACID) (View L-aspartic Acid (aspartic Acid) Review and L-aspartic Acid (aspartic Acid) Label ), OLMETEC (OLMESARTAN MEDOXOMIL) (View Olmetec (olmesartan Medoxomil) Review and Olmetec (olmesartan Medoxomil) Label ), ACTONEL (View Actonel Review and Actonel Label ).

6527952-8 | Hyperkalaemia
on Nov 18, 2009 Male patient from JAPAN , 41 years of age, was diagnosed with ascites and was treated with Torsemide (View Usage). Patient had the following side effects: hyperkalaemia. Torsemide dosage: 4 Mg (4 Mg, 1 In 1 D), Oral.

6505573-0 | Dehydration
on Dec 17, 2009 Male patient from UNITED STATES , 81 years of age, weighting 175.0 lb, was diagnosed with oedema and was treated with Torsemide (View Usage). After Torsemide was administered, patient had the following side effects: dehydration. Torsemide dosage: 20mg Pill 1/day Oral.

6491869-8 | Eosinophil Count Increased, Pruritus, Skin Exfoliation
Patient was taking Torsemide (View Usage). Patient experienced the following unwanted or unexpected effects: eosinophil count increased, pruritus, skin exfoliation on Nov 24, 2009 from JAPAN Additional patient health information: Male patient , 88 years of age, was diagnosed with oedema peripheral and. Torsemide dosage: 4 Mg (4 Mg, 1 In 1 D),oral. During the same period patient was treated with CARDENALIN (DOXAZOSIN MESYLATE) (View Cardenalin (doxazosin Mesylate) Review and Cardenalin (doxazosin Mesylate) Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), ITRACONAZOLE (View Itraconazole Review and Itraconazole Label ), TRANDOLAPRIL (View Trandolapril Review and Trandolapril Label ), AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ), SELBEX (TEPRENONE) (View Selbex (teprenone) Review and Selbex (teprenone) Label ), DIOVAN (View Diovan Review and Diovan Label ). Patient was hospitalized.

6485197-4 | Clavicle Fracture, Fall, Hepatocellular Injury, Inflammation, Liver Injury, Rash Erythematous, Renal Failure Acute, Rhabdomyolysis, Streptococcal Bacteraemia
Adverse event was reported on Nov 18, 2009 by a Male patient taking Torsemide (View Usage) (Dosage: ) . Location: , 94 years of age, Patient had the following side effects: clavicle fracture, fall (What is fall?), hepatocellular injury, inflammation, liver injury, rash erythematous, renal failure acute, rhabdomyolysis, streptococcal bacteraemia. During the same period patient was treated with ROCEPHIN (Intravenous Drip) (View Rocephin Review and Rocephin Label ), PENICILLIN G (View Penicillin G Review and Penicillin G Label ), AMOXICILLIN / CLAVULANIC ACID (AMOICILLIN, CLAVULANIC ACID) (Oral) (View Amoxicillin / Clavulanic Acid (amoicillin, Clavulanic Acid) Review and Amoxicillin / Clavulanic Acid (amoicillin, Clavulanic Acid) Label ), VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), ENOXAPARIN SODIUM (View Enoxaparin Sodium Review and Enoxaparin Sodium Label ), PERFALFAN (PARACETAMOL) (Intravenous Drip) (View Perfalfan (paracetamol) Review and Perfalfan (paracetamol) Label ), PRADIF (TAMSULOSIN) (Oral) (View Pradif (tamsulosin) Review and Pradif (tamsulosin) Label ), LASIX (Oral) (View Lasix Review and Lasix Label ).

6467275-9 | Acute Prerenal Failure, Asthenia, Dehydration, Dry Skin, Fluid Intake Reduced, Hyperkalaemia, Mucosal Dryness
on Nov 17, 2009 Female patient from GERMANY , 90 years of age, weighting 130.1 lb, was diagnosed with hypertension and was treated with Torsemide (View Usage). After Torsemide was administered, patient had the following side effects: acute prerenal failure, asthenia, dehydration, dry skin, fluid intake reduced, hyperkalaemia, mucosal dryness. Torsemide dosage: 20 Mg (10 Mg, 2 In 1 D) ,oral. During the same period patient was treated with BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE (5 Mg Bisoprolol/12.5 Mg Hydrochlorothiazide (1 Dosage Forms,1 In 1 D), Oral) (View Bisoprolol Fumarate And Hydrochlorothiazide Review and Bisoprolol Fumarate And Hydrochlorothiazide Label ), XIPAMIDE (XIPAMIDE) (20 Mg (20 Mg, 1 In 1 D), Oral) (View Xipamide (xipamide) Review and Xipamide (xipamide) Label ), LISINOPRIL (10 Mg (10 Mg,1 In 1 D), Oral) (View Lisinopril Review and Lisinopril Label ), GLIMEPIRIDE (View Glimepiride Review and Glimepiride Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ). Patient was hospitalized.

6443938-6 | Asthenia, Atrial Fibrillation, Decreased Activity, Electrocardiogram St Segment Depression, Haematocrit Decreased, Haemoglobin Decreased, Hyperglycaemia
on Oct 29, 2009 Male patient from , 65 years of age, weighting 183.0 lb, was diagnosed with hypertension, metastases to central nervous system and was treated with Torsemide (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, atrial fibrillation (What is atrial fibrillation?), decreased activity, electrocardiogram st segment depression, haematocrit decreased, haemoglobin decreased, hyperglycaemia. Torsemide dosage: 10 Mg (10 Mg, 1 In 1 D), Oral. During the same period patient was treated with DEXAMETHASONE TAB (Dose Reduction To 2mg/ Day (4 Mg, 3 In 1 D), Oral; 2 Mg (2 Mg, Daily), Oral) (View Dexamethasone Tab Review and Dexamethasone Tab Label ), ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ), BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), DIGITOXIN INJ (View Digitoxin Inj Review and Digitoxin Inj Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), OMEP (OMEPRAZOLE) (View Omep (omeprazole) Review and Omep (omeprazole) Label ), ACTRAPID NOVOLET (INSULIN HUMAN) (View Actrapid Novolet (insulin Human) Review and Actrapid Novolet (insulin Human) Label ). Patient was hospitalized.

6442454-5 | Cardiac Output Decreased, Condition Aggravated, Dyspnoea, Hyperkalaemia, Renal Failure Chronic, Unevaluable Event, Weight Decreased
Patient was taking Torsemide (View Usage). Patient had the following side effects: cardiac output decreased, condition aggravated, dyspnoea, hyperkalaemia, renal failure chronic, unevaluable event, weight decreased on Oct 28, 2009 from SWEDEN Additional patient health information: Male patient , 74 years of age, . Torsemide dosage: 10 Mg, 1 In 2 D, Oral. During the same period patient was treated with ENALAPRIL MALEATE (10 Mg, 1 In 1 2 D, Oral) (View Enalapril Maleate Review and Enalapril Maleate Label ), SINTROM (View Sintrom Review and Sintrom Label ), PLAVIX (View Plavix Review and Plavix Label ), CORDARONE (View Cordarone Review and Cordarone Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), DILATREND (CARVEDIOLOL) (View Dilatrend (carvediolol) Review and Dilatrend (carvediolol) Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), LANTUS (View Lantus Review and Lantus Label ). Patient was hospitalized.